Clinical Trials Browser

Phase 3 × Dexamethasone × Thoracic × Clear all

Carcinoma, Non-Small-Cell Lung

NCT00532155 2025-09-10

VITAL

Phase 3 Completed

913 enrolled 16 charts

Thoracic

Carcinoma, Lung Neoplasms

NCT04786964 2025-04-02

CONTERNO

Phase 3 Terminated

25 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02578680 2024-09-20

MK-3475-189

Phase 3 Completed

616 enrolled 19 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03950674 2024-06-10

MK-3475-189

Phase 3 Completed

40 enrolled 20 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT03033511 2021-07-29

MERU

Phase 3 Terminated

748 enrolled 13 charts

Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT03061812 2021-02-23

TAHOE

Phase 3 Completed

444 enrolled 16 charts

Thoracic

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT04201769 2020-04-03

LUNG-NEPA

Phase 3 Unknown

261 enrolled

Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT03334487 2018-12-26

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

Phase 3 Withdrawn

Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT00806819 2017-02-02

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Phase 3 Completed

718 enrolled 21 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3 Withdrawn

Thoracic

Lung Neoplasms, Nausea, Neoplasms, Vomiting

NCT00403065 2013-08-26

Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery

Phase 3 Completed

1,000 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Clinical Trials

MK-2870-009

VITAL

CONTERNO

MK-3475-189

MK-3475-189

MERU

TAHOE

LUNG-NEPA

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery